SL’s Credence Genomics to provide diagnostic services in India with Apollo Hospitals

Sri Lanka’s Credence Genomics will collaborate with India’s Apollo Hospitals Group to provide cutting-edge diagnostic services for infectious diseases for patients in India, starting with Chennai, Tamil Nadu.

The collaborators said the new line of tests is based on a specialized DNA diagnostics platform offering faster and more precise diagnosis.

“We are very excited to be exploring pioneering endeavours in which both companies could come together, to benefit society beyond the boundaries of countries and territories in the realm of medical science and its progress. This is also a major step for Sri Lanka and the local medical profession, as well as the country’s economy,” Credence Genomics founding CEO and Director Dr. Vaz Gnanam said.

Another highlight of this collaboration is ‘Beyond Biotec 2018’, which will be the first industry event highlighting successful commercial innovations in the private sector biotechnology space, along with opportunities in the research arena. 

The event will be graced by President Maithripala Sirisena along with Health Minister Dr. Rajitha Senaratne. 

Furthermore, Apollo Hospitals Enterprise Vice Chairman Preetha Reddy will also be present representing the collaboration, which is the first of its kind nationally. 
Beyond Biotec 2018 is sponsored by Credence Genomics and its Indian subsidiary Micro Genomics (India), along with Thermo Fischer Scientific, the world’s largest biotechnology company. 

According to Dr. Gnanam, Beyond Biotec 2018, which takes place on January 25, will be a landmark event bringing together the areas of healthcare, biotechnology and research.